Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Reduce −0.8% | 16,909,961 | $21.38 | $362M | −131,850 | +$28M | |
| New | 4,288,500 | $43.84 | $188M | +4,288,500 | +$188M | ||
| BHF - Brighthouse Finl | Reduce −4.5% | 3,341,600 | $43.42 | $145M | −158,400 | +$2M | |
| CEIXEUR - Consol Energy | Add +4.6% | 1,712,721 | $64.32 | $110M | +75,100 | +$29M | |
| TECK - Teck Resources · CL B | Add +7.5% | 2,164,198 | $30.41 | $66M | +151,700 | +$4M | |
| KD - Kyndryl | Add +34.9% | 7,251,000 | $8.27 | $60M | +1,877,600 | +$7M | |
| ODP1 - The Odp | Hold | 1,692,760 | $35.15 | $60M | — | — | |
| LIVN - Livanova | Add +81.1% | 812,400 | $50.77 | $41M | +363,800 | +$13M | |
| GLD - Spdr Gold Tr | Reduce −9.1% | 249,961 | $154.67 | $39M | −25,100 | −$8M | |
| CPRI - Capri | Add +5.3% | 988,500 | $38.44 | $38M | +49,400 | −$514K | |
| Southwestern Energy | Add +47.6% | 6,101,300 | $6.12 | $37M | +1,968,300 | +$12M | |
| REZI - Resideo Technologies | Add +0.2% | 1,570,083 | $19.06 | $30M | +3,800 | −$491K | |
| GPN - Global Pmts | Reduce −47.0% | 273,240 | $108.05 | $30M | −242,200 | −$28M | |
| SLV - Ishares Silver Tr | Hold | 1,558,000 | $17.50 | $27M | — | — | |
| WFRD - Weatherford Intl | Hold | 754,000 | $32.29 | $24M | — | — | |
| Change Healthcare | Reduce −45.3% | 801,701 | $27.49 | $22M | −665,174 | −$12M | |
| VSXY - Victorias Secret And | Reduce −7.8% | 684,681 | $29.12 | $20M | −57,800 | −$830K | |
| INTC - Intel | New | 715,000 | $25.77 | $18M | +715,000 | +$18M | |
| PKG - Graphic Packaging | Hold | 832,270 | $19.74 | $16M | — | — | |
| CIVI - Civitas Resources | Hold | 278,218 | $57.39 | $16M | — | — | |
| GPRO - Gopro · CL A | Hold | 2,697,200 | $4.93 | $13M | — | — | |
| CNXC - Concentrix | Add +146.9% | 110,467 | $111.64 | $12M | +65,734 | +$6M | |
| LKFT - Galapagos | Hold | 146,388 | $42.64 | $6M | — | — | |
| Danimer Scientific · CL A | Add +134.5% | 1,924,940 | $2.95 | $6M | +1,103,940 | +$2M | |
| NWSA - NEWS · CL B | Hold | 361,291 | $15.42 | $6M | — | — | |
| CNX - Cnx Res | Hold | 222,715 | $15.53 | $3M | — | — | |
| Waverley Capital Acquis | Hold | 350,000 | $9.79 | $3M | — | — | |
| Finserv Acquisition Ii | Hold | 315,000 | $9.81 | $3M | — | — | |
| Panacea Acquisition Ii · CL A | Hold | 275,000 | $9.80 | $3M | — | — | |
| RIVN - Rivian Automotive · CL A | Hold | 73,723 | $32.92 | $2M | — | — | |
| GANX - Gain Therapeutics | Hold | 546,560 | $3.26 | $2M | — | — | |
| Talis Biomedical | Hold | 2,235,783 | $0.6816 | $2M | — | — | |
| Neubase Therapeutics | Hold | 2,727,027 | $0.3949 | $1M | — | — | |
| Polestar Automotive UK | Hold | 82,100 | $1.10 | $90K | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $2.23 | $78K | — | — | |
| 23andme · CLASS A | Hold | 23,591 | $2.84 | $67K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2022 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Holding | Exit | 0 | $61.71 | $82M | −1,327,898 | −$82M | |
| CC - Chemours | Exit | 0 | $32.02 | $22M | −700,000 | −$22M | |
| WBD - Warner Bros Discovery | Exit | 0 | $13.42 | $22M | −1,652,000 | −$22M | |
| International Seaways | Exit | 0 | $21.20 | $10M | −449,130 | −$10M | |
| PLBY Group | Exit | 0 | $6.40 | $5M | −820,000 | −$5M | |
| ASTS - Ast Spacemobile · CL A | Exit | 0 | $6.28 | $3M | −427,500 | −$3M | |
| XLE - Select Sector Spdr Tr | Exit | 0 | $71.50 | $1M | −14,700 | −$1M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2